More recently, loss of alpha-thalassemia/mental retardation syndrome X-linked (ATRX) has been shown to further refine IDH-mutant astrocytic tumors with IDH/ATRX mutant-tumors carrying a more favorable prognosis (10). The gene discussed is IDH2; the disease is Alpha-thalassemia.